Contemporary OB/GYN published an FAQ on September 30, 2026, explaining what the change in name from PCOS to PMOS means for patients, according to the outlet. The piece addresses the terminology shift directly for clinicians who treat the condition.
The rename has drawn attention across several outlets in recent days. Labiotech.eu examined the current state of the therapeutic field under the heading "From PCOS to PMOS," while Women's Health Magazine ran an op-ed by a reproductive endocrinologist who described difficulty obtaining her own PMOS diagnosis. A separate item in Sports Chosun listed irregular periods, weight gain and worsening acne as reasons to suspect polycystic ovary syndrome. Another piece, an "Ask the Expert" segment on fertility sponsored by Fertility Answers, appeared in 225 Magazine.
Taken together, the coverage suggests the name change is being discussed alongside questions about how the condition is recognized and treated. Contemporary OB/GYN's FAQ frames the rename as a practical matter for patient care, though the available summary does not detail the clinical reasoning behind the new term.
The reporting does not include specifics on when the rename was formally adopted, which bodies endorsed it, or how diagnostic criteria may change. Those details are not present in the source material.
What to watch next: whether professional societies issue formal guidance on the PMOS terminology and whether diagnostic criteria are updated to match the new name.
